The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
The partnership will enable rapid and reliable product delivery
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Subscribe To Our Newsletter & Stay Updated
